Skip to main content
. Author manuscript; available in PMC: 2013 Oct 23.
Published in final edited form as: Pancreatology. 2012 Jun 15;12(4):358–363. doi: 10.1016/j.pan.2012.05.011

Figure 1. Survival curves.

Figure 1

A) Survival by FH of PC. B) Survival by personal history of another malignancy (prior to/concurrent with IPMN). NOM = no other pre-IPMN/concurrent malignancy, POM = presence of other pre-IPMN/concurrent malignancy. C) Survival by presence of invasive carcinoma within the IPMN.